Advance your global drug development in China faster

Navigate your study’s complexities with a collaborative lab partner that offers you global resources with a localized approach. Whether you're conducting your drug development in China or looking to expand it globally, our experience in China means your projects receive the attention and precision they deserve, all with communicating in your preferred language.

Labcorp China has been a trusted lab partner in global drug development since 1998 when we opened our first office in Beijing. Today, our state-of-the-art facilities span 21,000 m², providing the study capacity you need to progress through the drug development continuum quickly and bring life-changing therapies to patients more efficiently.

Industry-leading laboratory services for your global drug development projects

From nonclinical, bioanalytical, immunology and immunotoxicology to central laboratory services, Labcorp is your science and laboratory partner for every stage of development. Featuring globally aligned standard operating procedures, technical platforms and experienced teams, our facilities in China have a proven record of regulatory compliance while maintaining global data combinability.

Bioanalytical services

Gain support for your preclinical GLP toxicology studies and clinical bioanalysis with comprehensive liquid chromatography tandem mass spectrometry (LC-MS/MS) and immunochemistry platforms, as well as services adhering to standardized global operating procedures. Our key bioanalytical capabilities include:

Global regulatory inspection/accreditation records

Central laboratory services

Receive consistent and high-quality data through our globally standardized methods and processes. Operating since 2007, our Shanghai central laboratory services site offers:

Core services

Global regulatory inspection / accreditation records